I have a personal opinion that the company is being hauled upon badly by the analysts, fund managers and others with their IN-VALUABLE recos. One should congratulate the company for coming out with the drug. Regarding Q4 financials, Q3 was good and after that there were good developments. Despite the results, the virus is spreading and it seems to be spreading fast. Also, the product can be exported to other countries. It seems the ANALYSTS have not intentionally cited this.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。